Seòmar agus comataidhean

The Scottish Government draft budget 2025-26 has been informed by planning forecasts provided by the Thrombectomy Advisory Group (TAG). Clinicians and third sector organisations, as well as NHS planning colleagues, are represented on the TAG and the information provided by them helps to inform decisions taken by the National Thrombectomy Programme Board.

Work is ongoing to establish how the £16 million funding announced in the Scottish budget, subject to parliamentary scrutiny, will be best used to maximise the number of patients able to benefit from thrombectomy.

Work is ongoing to establish how the £16 million funding announced in the draft Scottish budget will be best used to maximise the number of patients able to benefit from thrombectomy.

The new Scottish Budget was presented to Parliament on 4 December 2024 with £16 million allocated to the further development of the thrombectomy service and stroke policy. This details Scottish Ministers spend proposals for the year ahead and the Scottish Parliament will then scrutinise this information through the Scottish Budget Bill. Further details on the Scottish Budget and the Health and Social Care portfolio budget Finance can be found at; Scottish Budget 2025 to 2026.

As set out in the answer to question S6W-33241 on 24 January 2025, Screening Oversight and Assurance Scotland are developing a business case for the implementation of a targeted lung screening programme, which is expected by the end of February 2025.

Following receipt, the Scottish Screening Committee will be convened to discuss its findings and consider next steps.

All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

Screening Oversight and Assurance Scotland, supported by the work of an expert advisory group and led by the Director of Screening, is currently developing a business case for implementation of targeted lung screening. This is expected by the end of this winter, and will consider the matter of incidental findings. Following receipt of the business case, the Scottish Government and delivery partners across the NHS will have greater scope to make an evidenced-based assessment of implementation timescales.

The roll-out of any screening programme is a complex undertaking, and the UK National Screening Committee acknowledged in its recommendation that there remain a number of significant issues that must be worked through before a full programme of lung screening can be implemented. This means a national screening programme is likely to take years rather than months to implement.

In the meantime, lung cancer remains a national priority. The Scottish Government has a dedicated chapter in our £114.5 million National Cancer Plan, and in December 2023 we redesigned lung cancer diagnostic services to help ensure patients receive faster access to treatment.

I refer the member to the answer to question S6W-33241 on 24 January 2025. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

Within the Scottish Government, funding for Health and Care Research comes under the policy remit of the Chief Scientist Office (CSO)

CSO directly funds research through its research project and fellowship schemes. These are open to applications from across the clinical spectrum. All applications go through the same independent expert review process to enable funding decisions to be made

For multi-year projects and fellowships, the funding figure is allocated to the year corresponding to the start date and is the total amount committed to the project or fellowship

The 4 categories listed have been interpreted as follows:

Dementia - category including Alzheimer's; Frontotemporal Lobe Dementia; Lewy Body Dementia

This information is not held centrally by either Scottish Government or Public Health Scotland (PHS).

There are no plans to expand eligibility of The Young Patients Family Fund (YPFF) at this time.

In addition to support available under the YPFF, financial support for travel to hospital is available via the patient travel expenses reimbursement schemes. Under those schemes, patients and authorised escorts can reclaim reasonable costs of travel associated with attending a hospital appointment, in line with eligibility criteria and medical requirements.

Priorities for the Scottish Government are:

• national implementation of the Scottish Epilepsy Register,
• further adoption of successful approaches to improving services through the neurological conditions network,
• continued improvements in provision of ‘social support’ and psychological services for people with neurological conditions,
• continued development and adoption of condition specific care pathways,
• continued development and adoption of approaches to workforce planning and training for nursing, pharmacy, neuropsychology allied health professionals, and neurophysiology.

This work will be considered as part of the development of the Long Term Conditions Strategy due to be published later this year. Any required funding will be considered during the 2025-26 budget deliberations.

The largest proportion of funding has been awarded to projects that improve services for all or more than one neurological condition, including services for carers. Direct investment was also made to projects for the following specific conditions:

• Acquired Brain Injury
• Cerebral Palsy
• Epilepsy
• Functional Neurological Disorder (FND)
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
• Migraine
• Multiple Sclerosis (MS)
• Parkinson’s Disease
• Progressive Supranuclear Palsy (PSP)
• Psychogenic Non-Epileptic Seizures
• Spina bifida/ hydrocephalus

A full list of projects funded through the Neurological Framework can be found here.